MEDICLIN Aktiengesellschaft (FRA:MED)

FRA:MED Statistics

Total Valuation

FRA:MED has a market cap or net worth of EUR 163.40 million. The enterprise value is 494.34 million.

Market Cap	163.40M
Enterprise Value	494.34M

Important Dates

The last earnings date was Tuesday, November 4, 2025.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	Jun 5, 2025

Share Statistics

Current Share Class	47.50M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	-3.83%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	36.92%
Float	11.44M

Valuation Ratios

The trailing PE ratio is 4.66.

PE Ratio	4.66
Forward PE	n/a
PS Ratio	0.21
PB Ratio	0.66
P/TBV Ratio	0.72
P/FCF Ratio	3.11
P/OCF Ratio	1.69
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.22, with an EV/FCF ratio of 9.42.

EV / Earnings	14.10
EV / Sales	0.62
EV / EBITDA	4.22
EV / EBIT	7.63
EV / FCF	9.42

Financial Position

The company has a current ratio of 1.93, with a Debt / Equity ratio of 1.80.

Current Ratio	1.93
Quick Ratio	1.86
Debt / Equity	1.80
Debt / EBITDA	3.83
Debt / FCF	8.53
Interest Coverage	3.09

Financial Efficiency

Return on equity (ROE) is 15.32% and return on invested capital (ROIC) is 5.84%.

Return on Equity (ROE)	15.32%
Return on Assets (ROA)	4.46%
Return on Invested Capital (ROIC)	5.84%
Return on Capital Employed (ROCE)	8.67%
Revenue Per Employee	113,839
Profits Per Employee	5,026
Employee Count	10,472
Asset Turnover	0.87
Inventory Turnover	85.26

Taxes

In the past 12 months, FRA:MED has paid 12.01 million in taxes.

Income Tax	12.01M
Effective Tax Rate	25.40%

Stock Price Statistics

The stock price has increased by +36.59% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+36.59%
50-Day Moving Average	3.35
200-Day Moving Average	3.02
Relative Strength Index (RSI)	44.68
Average Volume (20 Days)	94

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:MED had revenue of EUR 793.91 million and earned 35.05 million in profits. Earnings per share was 0.74.

Revenue	793.91M
Gross Profit	183.60M
Operating Income	64.70M
Pretax Income	47.29M
Net Income	35.05M
EBITDA	88.05M
EBIT	64.70M
Earnings Per Share (EPS)	0.74

Balance Sheet

The company has 117.29 million in cash and 447.78 million in debt, giving a net cash position of -330.48 million.

Cash & Cash Equivalents	117.29M
Total Debt	447.78M
Net Cash	-330.48M
Net Cash Per Share	n/a
Equity (Book Value)	248.10M
Book Value Per Share	5.21
Working Capital	153.41M

Cash Flow

In the last 12 months, operating cash flow was 96.67 million and capital expenditures -44.19 million, giving a free cash flow of 52.47 million.

Operating Cash Flow	96.67M
Capital Expenditures	-44.19M
Free Cash Flow	52.47M
FCF Per Share	n/a

Margins

Gross margin is 23.13%, with operating and profit margins of 8.15% and 4.42%.

Gross Margin	23.13%
Operating Margin	8.15%
Pretax Margin	5.96%
Profit Margin	4.42%
EBITDA Margin	11.09%
EBIT Margin	8.15%
FCF Margin	6.61%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 1.19%.

Dividend Per Share	0.04
Dividend Yield	1.19%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	5.42%
Buyback Yield	n/a
Shareholder Yield	1.19%
Earnings Yield	21.45%
FCF Yield	32.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:MED has an Altman Z-Score of 1.54 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.54
Piotroski F-Score	8